These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2190532)

  • 21. [Chemotherapy in prostatic carcinoma].
    Pérez Manga G; Arranz Arija JA; García Gómez R; Salinas Hernández P; González del Val R
    Arch Esp Urol; 1993 Mar; 46(2):116-26. PubMed ID: 8498851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current treatment of advanced prostate cancer.
    Ismail M; Gomella LG
    Tech Urol; 1997; 3(1):16-24. PubMed ID: 9170220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ; Mancini I
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of chemotherapy in prostate cancer. Minireview.
    Odrázka K; Vanásek J; Vaculíková M; Stejskal J; Filip S
    Neoplasma; 2000; 47(4):197-203. PubMed ID: 11043822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment for hormone-refractory or relapsing prostatic cancer].
    Hirao Y; Ozono S; Okajima E
    Gan To Kagaku Ryoho; 1996 Mar; 23(4):418-26. PubMed ID: 8678492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physician attitudes toward cytotoxic chemotherapy use in patients with advanced prostate carcinoma.
    Oh WK; Tully P; Kantoff PW; Regan MM
    Cancer; 2003 May; 97(9):2171-9. PubMed ID: 12712468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapy for localized, high-risk prostate cancer.
    Narayan S; Smith DC; Sandler HM
    Semin Radiat Oncol; 2003 Apr; 13(2):152-7. PubMed ID: 12728444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The study landscape for prostate cancer].
    Miller K
    Urologe A; 2005 Dec; 44(12):1431-4. PubMed ID: 16292461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormone stimulation and chemotherapy in advanced prostate cancer: interim analysis of an ongoing randomized trial.
    Manni A; Santen RJ; Boucher AE; Lipton A; Harvey H; Simmonds M; White-Hershey D; Gordon RA; Rohner T; Drago J
    Anticancer Res; 1986; 6(2):309-14. PubMed ID: 3518596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Advanced prostate cancer--a therapeutic dilemma?].
    Rübben H; Altwein JE
    Urologe A; 1987 Jan; 26(1):7-14. PubMed ID: 3576864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy of hormonally unresponsive prostatic carcinoma.
    deKernion JB; Lindner A
    Urol Clin North Am; 1984 May; 11(2):319-26. PubMed ID: 6233779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy of advanced cancer of the prostate.
    Wirth MP
    Prog Clin Biol Res; 1990; 350():159-70. PubMed ID: 2201042
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of UFT on treatment of urological cancer--effect of UFT on treatment of invasive bladder cancer and advanced prostate cancer. Ibaraki Urological Cancer Chemotherapy Study Group].
    Uchida K; Takeshima H; Kikuchi K; Shimazui T; Miyanaga N; Kawai K; Akaza H; Tsuchiya A; Noguchi R; Hattori K; Manabe F; Matsuki K; Suzuki R; Ishikawa S; Kondo F; Kobayashi T; Koiso K
    Gan To Kagaku Ryoho; 1998 Jul; 25(8):1179-87. PubMed ID: 9679581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innovative approaches to the hormonal treatment of advanced prostate cancer.
    Trachtenberg J
    Eur Urol; 1997; 32 Suppl 3():78-80. PubMed ID: 9267790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New drugs at the horizon for men with prostate cancer].
    Shabafrouz K; Bauer J; Berthold DR
    Rev Med Suisse; 2010 May; 6(250):1057-8, 1060-1. PubMed ID: 20564864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Future developments of nonhormonal systemic therapy for prostatic carcinoma.
    Warner JA; Heston WD
    Urol Clin North Am; 1991 Feb; 18(1):25-33. PubMed ID: 1992572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Androgen priming and cytotoxic chemotherapy in advanced prostatic cancer.
    Suarez AJ; Lamm DL; Radwin HM; Sarosdy M; Clark G; Osborne CK
    Cancer Chemother Pharmacol; 1982; 8(3):261-5. PubMed ID: 7127658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Does chemotherapy have a role in the treatment of prostatic cancer?].
    Verbaeys A
    Acta Urol Belg; 1991; 59(4):53-4. PubMed ID: 1819203
    [No Abstract]   [Full Text] [Related]  

  • 39. [The future of chemotherapy of prostatic cancer].
    Grillo-López AJ; Vélez-García E
    Bol Asoc Med P R; 1975 Nov; 67(11):327-30. PubMed ID: 1060454
    [No Abstract]   [Full Text] [Related]  

  • 40. Chemotherapy for prostate cancer.
    Dyrstad SW; Shah P; Rao K
    Curr Pharm Des; 2006; 12(7):819-37. PubMed ID: 16515498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.